Ventas Inc Stock News

Ventas, Inc.'s senior housing operating portfolio showed strong performance in Q4 2023, with net operating income up 15%. The 2024 guidance for Ventas was weaker than expected. We examine our earlier

While the top- and bottom-line numbers for Ventas (VTR) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare

Ventas (VTR) came out with quarterly funds from operations (FFO) of $0.76 per share, in line with the Zacks Consensus Estimate. This compares to FFO of $0.73 per share a year ago.

Favorable SHOP operating trends, healthy demand for life-science real estate assets and accretive investments are likely to have benefited Ventas' (VTR) Q4 earnings.

Ventas (VTR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Get a deeper insight into the potential performance of Ventas (VTR) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for som

We have narrowed our search to five dividend-paying large-cap stocks that are poised to beat on earnings next week. These are: WM, QSR, TAP, LDOS, VTR.

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) will issue its fourth quarter 2023 earnings release after the close of trading on the New York Stock Exchange on Wednesday, February 14, 2024. A conf

In 2023, real estate stocks experienced a rollercoaster journey, mirroring broader market fluctuations. The year began on a shaky note, with both commercial and residential sectors feeling the pinch o

A rise in healthcare spending by senior citizens and accretive investments in the research portfolio bode well for Ventas (VTR). However, dependence on a few tenants and high interest rates are woes.

The real estate sector is a big deal in our economy. Beyond bricks and mortar, the sector creates jobs, services, and growth across the continental United States.

REITWorld conference in Los Angeles featured 29 meetings, including exclusive sessions with REIT CEOs and CFOs, and property tours. Common themes discussed included cautious optimism on 2024 fundament

Ventas, a healthcare REIT, has underperformed the market due to the pandemic and high interest rates. The company is starting to recover, with strong demand for its properties and favorable supply-dem

Ventas beats Q3'23 earnings estimates with FFO/share of $0.75 and revenue of $1.15bn. Wedbush and BMO Capital Markets upgrade or maintain outperform rating on Ventas. Ventas focuses on senior care and

Ventas reported respectable third-quarter earnings, with strength in its senior housing business. Welltower reported good quarterly results as well.